{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":6,"sponsored":0,"items":[{"id":"n_43zb4ijsajhikzei3txa","seq":1443649,"kind":"article","title":"Head-To-Head Review: Greenpro Capital (NASDAQ:GRNQ) versus Oppenheimer (NYSE:OPY)","url":"https://www.themarketsdaily.com/2026/10/02/head-to-head-review-greenpro-capital-nasdaqgrnq-versus-oppenheimer-nyseopy.html","published":"2026-10-02T22:45:00Z","seen":"2026-10-02T22:48:53Z","lang":"en","source":{"id":"themarketsdaily.com","name":"themarketsdaily.com","domain":"themarketsdaily.com"},"via":"gdelt-gkg-english","topics":["business","economy","education"],"authors":["Kim Johansen"],"entities":[{"id":"Q108839994","name":"Oppenheimer","type":"org"},{"id":"Q44539","name":"temple","type":"org"}],"story":"st_43zb4ijsajhikzei3txa","category":"economy-business","category_p":0.65,"sentiment":"neutral","tone":0.22,"political":0.16},{"id":"n_2zensztb76rlyrnxreaq","seq":1405851,"kind":"article","title":"Oppenheimer Issues Pessimistic Forecast for Modine Manufacturing (NYSE:MOD) Stock Price","url":"https://www.tickerreport.com/banking-finance/13606645/oppenheimer-issues-pessimistic-forecast-for-modine-manufacturing-nysemod-stock-price.html","published":"2026-10-02T18:06:44Z","seen":"2026-10-02T18:06:44Z","lang":"en","source":{"id":"tickerreport.com","name":"tickerreport.com","domain":"tickerreport.com"},"via":"gdelt-gkg-english","topics":["economy","business"],"authors":["Joseph Griffin"],"entities":[{"id":"Q108839994","name":"Oppenheimer","type":"person"},{"id":"Q1509926","name":"Modine","type":"org"}],"story":"st_2zensztb76rlyrnxreaq","category":"economy-business","category_p":0.8,"sentiment":"negative","tone":-0.21,"political":0.07},{"id":"n_sotd3af3euqpj6p7cilq","seq":755922,"kind":"article","title":"Salesforce in focus as Oppenheimer reiterates Outperform rating after customer survey (CRM:NYSE)","url":"https://seekingalpha.com/news/4648183-salesforce-in-focus-as-oppenheimer-reiterates-outperform-rating-after-customer-survey","published":"2026-09-29T19:13:00Z","seen":"2026-09-29T19:39:25Z","lang":"en","source":{"id":"seekingalpha.com","name":"seekingalpha.com","domain":"seekingalpha.com","outlet":{"wikidata":"Q3477676","name":"Seeking Alpha","type":"other","country":"US","designations":["dot-com company"]}},"via":"gdelt-gkg-english","topics":["economy"],"entities":[{"id":"Q941127","name":"Salesforce","type":"org"},{"id":"Q108839994","name":"Oppenheimer","type":"org"}],"story":"st_sotd3af3euqpj6p7cilq","category":"economy-business","category_p":0.71,"sentiment":"neutral","tone":0.59,"political":0.04},{"id":"n_5x647jpx3uorzrg3z77q","seq":669623,"kind":"article","title":"Oppenheimer actor asked Christopher Nolan to settle a Tenet debate with his son and was \"embarrassed\" by the \"obvious\" answer: \"I haven't called him again\"","url":"https://www.gamesradar.com/entertainment/sci-fi-movies/oppenheimer-actor-asked-christopher-nolan-to-settle-a-tenet-debate-with-his-son-and-was-embarrassed-by-the-obvious-answer-i-havent-called-him-again","published":"2026-09-29T12:38:17Z","seen":"2026-09-29T12:38:17Z","lang":"en","source":{"id":"gamesradar.com","name":"gamesradar.com","domain":"gamesradar.com","outlet":{"wikidata":"Q960011","name":"Q960011","type":"website","country":"GB","designations":["video game news website"]}},"via":"gdelt-gkg-english","topics":["education","economy"],"authors":["Molly Edwards"],"entities":[{"id":"Q108839994","name":"Oppenheimer","type":"person"},{"id":"Q25191","name":"Christopher Nolan","type":"person"},{"id":"Q63985561","name":"Tenet","type":"event"}],"story":"st_5x647jpx3uorzrg3z77q","category":"arts-culture-entertainment","category_p":0.45,"category2":"politics","sentiment":"neutral","tone":-0.04,"political":0.27},{"id":"n_u3t37gfo6b3kue7l44kq","seq":577688,"kind":"article","title":"Was 'Oppenheimer' Better Than 'The Odyssey?'","url":"https://crooksandliars.com/2026/09/was-oppenheimer-better-odyssey","published":"2026-09-29T03:00:00Z","seen":"2026-09-29T04:42:15Z","lang":"en","source":{"id":"crooksandliars.com","name":"crooksandliars.com","domain":"crooksandliars.com","outlet":{"wikidata":"Q5187910","name":"Crooks and Liars","type":"website","designations":["website"]}},"via":"gdelt-gkg-english","topics":["science","economy"],"authors":["John Amato"],"entities":[{"id":"Q108839994","name":"Oppenheimer","type":"other"},{"id":"Q35160","name":"Odyssey","type":"other"}],"story":"st_u3t37gfo6b3kue7l44kq","category":"arts-culture-entertainment","category_p":0.54,"sentiment":"neutral","tone":-0.02,"political":0.02},{"id":"n_d6mo3l4tsepoyp3pthsq","seq":514871,"kind":"article","title":"Why Oppenheimer Cut Boston Scientific's Price Target by $20 Despite Keeping its Outperform Rating","url":"https://www.insidermonkey.com/news/why-oppenheimer-cut-boston-scientifics-price-target-by-20-despite-keeping-its-outperform-rating-1845826","published":"2026-09-28T20:08:19Z","seen":"2026-09-28T20:08:19Z","lang":"en","source":{"id":"insidermonkey.com","name":"insidermonkey.com","domain":"insidermonkey.com"},"via":"gdelt-gkg-english","topics":["technology","economy","health","business"],"authors":["Noor Ul Ain Rehman"],"entities":[{"id":"Q108839994","name":"Oppenheimer","type":"org"},{"id":"Q894585","name":"Boston Scientific","type":"org"}],"story":"st_d6mo3l4tsepoyp3pthsq","category":"economy-business","category_p":0.65,"sentiment":"neutral","tone":-0.22,"political":0.01}]}